Patients Patient adherence – the key to restoring trust in pharma Medication is a staple of modern medicine, with almost 50% of adults in the United Sta
Patients Transparency, social change can help pharma regain the publi... Trust in life science companies has fluctuated since the start of the pandemic.
Views & Analysis How can pharma companies win the trust of Generation Z? The information age has produced a generation of young people concerned about their health, but distrustful of big brands – and that includes the pharmaceutical industry.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.